218 related articles for article (PubMed ID: 21257714)
1. Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis.
Marquer C; Devauges V; Cossec JC; Liot G; Lécart S; Saudou F; Duyckaerts C; Lévêque-Fort S; Potier MC
FASEB J; 2011 Apr; 25(4):1295-305. PubMed ID: 21257714
[TBL] [Abstract][Full Text] [Related]
2. Low-density lipoprotein receptor-related protein promotes amyloid precursor protein trafficking to lipid rafts in the endocytic pathway.
Yoon IS; Chen E; Busse T; Repetto E; Lakshmana MK; Koo EH; Kang DE
FASEB J; 2007 Sep; 21(11):2742-52. PubMed ID: 17463224
[TBL] [Abstract][Full Text] [Related]
3. Impact of cholesterol level upon APP and BACE proximity and APP cleavage.
von Arnim CA; von Einem B; Weber P; Wagner M; Schwanzar D; Spoelgen R; Strauss WL; Schneckenburger H
Biochem Biophys Res Commun; 2008 May; 370(2):207-12. PubMed ID: 18374657
[TBL] [Abstract][Full Text] [Related]
4. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts.
Ehehalt R; Keller P; Haass C; Thiele C; Simons K
J Cell Biol; 2003 Jan; 160(1):113-23. PubMed ID: 12515826
[TBL] [Abstract][Full Text] [Related]
5. BACE1 interacts with lipid raft proteins.
Hattori C; Asai M; Onishi H; Sasagawa N; Hashimoto Y; Saido TC; Maruyama K; Mizutani S; Ishiura S
J Neurosci Res; 2006 Sep; 84(4):912-7. PubMed ID: 16823808
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by KMI-574 leads to dislocalization of BACE1 from lipid rafts.
Ebina M; Futai E; Tanabe C; Sasagawa N; Kiso Y; Ishiura S
J Neurosci Res; 2009 Feb; 87(2):360-8. PubMed ID: 18798280
[TBL] [Abstract][Full Text] [Related]
7. The role of low-density receptor-related protein 1 (LRP1) as a competitive substrate of the amyloid precursor protein (APP) for BACE1.
von Einem B; Schwanzar D; Rehn F; Beyer AS; Weber P; Wagner M; Schneckenburger H; von Arnim CA
Exp Neurol; 2010 Sep; 225(1):85-93. PubMed ID: 20685197
[TBL] [Abstract][Full Text] [Related]
8. Gamma-secretase activity is present in rafts but is not cholesterol-dependent.
Wada S; Morishima-Kawashima M; Qi Y; Misono H; Shimada Y; Ohno-Iwashita Y; Ihara Y
Biochemistry; 2003 Dec; 42(47):13977-86. PubMed ID: 14636066
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol-dependent energy transfer between fluorescent proteins-insights into protein proximity of APP and BACE1 in different membranes in Niemann-Pick type C disease cells.
von Einem B; Weber P; Wagner M; Malnar M; Kosicek M; Hecimovic S; Arnim CA; Schneckenburger H
Int J Mol Sci; 2012 Nov; 13(12):15801-12. PubMed ID: 23443094
[TBL] [Abstract][Full Text] [Related]
10. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
Harris B; Pereira I; Parkin E
Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
[TBL] [Abstract][Full Text] [Related]
11. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.
Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ
J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051
[TBL] [Abstract][Full Text] [Related]
12. Effects of sulindac sulfide on the membrane architecture and the activity of gamma-secretase.
Gamerdinger M; Clement AB; Behl C
Neuropharmacology; 2008 May; 54(6):998-1005. PubMed ID: 18359496
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer disease Abeta production in the absence of S-palmitoylation-dependent targeting of BACE1 to lipid rafts.
Vetrivel KS; Meckler X; Chen Y; Nguyen PD; Seidah NG; Vassar R; Wong PC; Fukata M; Kounnas MZ; Thinakaran G
J Biol Chem; 2009 Feb; 284(6):3793-803. PubMed ID: 19074428
[TBL] [Abstract][Full Text] [Related]
14. Measurement of cellular beta-site of APP cleaving enzyme 1 activity and its modulation in neuronal assay systems.
Volbracht C; Penzkofer S; Mansson D; Christensen KV; Fog K; Schildknecht S; Leist M; Nielsen J
Anal Biochem; 2009 Apr; 387(2):208-20. PubMed ID: 19454261
[TBL] [Abstract][Full Text] [Related]
15. Alterations in phosphatidylethanolamine levels affect the generation of Aβ.
Nesic I; Guix FX; Vennekens K; Michaki V; Van Veldhoven PP; Feiguin F; De Strooper B; Dotti CG; Wahle T
Aging Cell; 2012 Feb; 11(1):63-72. PubMed ID: 22023223
[TBL] [Abstract][Full Text] [Related]
16. BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild-type mice.
Nishitomi K; Sakaguchi G; Horikoshi Y; Gray AJ; Maeda M; Hirata-Fukae C; Becker AG; Hosono M; Sakaguchi I; Minami SS; Nakajima Y; Li HF; Takeyama C; Kihara T; Ota A; Wong PC; Aisen PS; Kato A; Kinoshita N; Matsuoka Y
J Neurochem; 2006 Dec; 99(6):1555-63. PubMed ID: 17083447
[TBL] [Abstract][Full Text] [Related]
17. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1.
Sankaranarayanan S; Price EA; Wu G; Crouthamel MC; Shi XP; Tugusheva K; Tyler KX; Kahana J; Ellis J; Jin L; Steele T; Stachel S; Coburn C; Simon AJ
J Pharmacol Exp Ther; 2008 Mar; 324(3):957-69. PubMed ID: 18156464
[TBL] [Abstract][Full Text] [Related]
18. A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivo.
Atwal JK; Chen Y; Chiu C; Mortensen DL; Meilandt WJ; Liu Y; Heise CE; Hoyte K; Luk W; Lu Y; Peng K; Wu P; Rouge L; Zhang Y; Lazarus RA; Scearce-Levie K; Wang W; Wu Y; Tessier-Lavigne M; Watts RJ
Sci Transl Med; 2011 May; 3(84):84ra43. PubMed ID: 21613622
[TBL] [Abstract][Full Text] [Related]
19. Control of APP processing and Abeta generation level by BACE1 enzymatic activity and transcription.
Li Y; Zhou W; Tong Y; He G; Song W
FASEB J; 2006 Feb; 20(2):285-92. PubMed ID: 16449801
[TBL] [Abstract][Full Text] [Related]
20. Preferred Endocytosis of Amyloid Precursor Protein from Cholesterol-Enriched Lipid Raft Microdomains.
Cho YY; Kwon OH; Chung S
Molecules; 2020 Nov; 25(23):. PubMed ID: 33255194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
